Published in Am J Cardiol on April 24, 1987
The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. Br J Clin Pharmacol (1992) 0.82
Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency. Br J Clin Pharmacol (1991) 0.81
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat. BMC Clin Pharmacol (2006) 0.81
Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency. Eur J Clin Pharmacol (2009) 0.78
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril. Br J Clin Pharmacol (1993) 0.76
NO at work. Cell (1994) 5.07
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99
Response of naïve and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol (2000) 4.08
The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J (1995) 3.69
cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem (1994) 2.95
Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture. Proc Natl Acad Sci U S A (1980) 2.84
A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of mammalian cells. EMBO J (1995) 2.68
The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J (1992) 2.58
The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta (1993) 2.54
The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J Biol Chem (1999) 2.31
Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A (1991) 2.15
Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem (1998) 2.14
Early diagnosis of brain death in patients treated with central nervous system depressant drugs. Transplantation (2000) 2.07
Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP. EMBO J (1995) 1.88
The bacterial actin nucleator protein ActA of Listeria monocytogenes contains multiple binding sites for host microfilament proteins. Curr Biol (1995) 1.83
NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost (2008) 1.81
Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem (1990) 1.81
Mutants of Neurospora crassa deficient in ornithine-delta-transmainase. J Bacteriol (1968) 1.80
Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci (1997) 1.80
Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein). Proc Natl Acad Sci U S A (1995) 1.74
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology (2000) 1.72
Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol (1999) 1.71
Detection of dengue virus neutralizing antibodies in bats from Costa Rica and Ecuador. J Med Entomol (2000) 1.70
Correlating factors and clinical significance of flexible flatfoot in preschool children. J Pediatr Orthop (2001) 1.68
Genetic and physiological characterization of a Rhizobium etli mutant strain unable to synthesize poly-beta-hydroxybutyrate. J Bacteriol (1996) 1.66
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res (2000) 1.60
Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun (2001) 1.60
Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci U S A (1999) 1.50
[ALPHA-fitness test battery: health-related field-based fitness tests assessment in children and adolescents]. Nutr Hosp (2012) 1.50
YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol (1998) 1.49
Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 1.49
Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem (1994) 1.48
Pacifier use, early weaning, and cry/fuss behavior: a randomized controlled trial. JAMA (2001) 1.48
Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem (1989) 1.48
Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets. J Thromb Haemost (2008) 1.47
Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Eur J Gastroenterol Hepatol (2001) 1.46
Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci (2001) 1.45
Regulation of glutamine synthetase in fed-batch cultures of Neurospora crassa. Biochem Biophys Res Commun (1977) 1.44
VASP interaction with vinculin: a recurring theme of interactions with proline-rich motifs. FEBS Lett (1996) 1.44
Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut (2005) 1.44
Fermentative and aerobic metabolism in Rhizobium etli. J Bacteriol (1995) 1.43
Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol (1995) 1.42
KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem (2000) 1.41
Heterogeneous distribution of the cAMP receptor protein RII in the nervous system: evidence for its intracellular accumulation on microtubules, microtubule-organizing centers, and in the area of the Golgi complex. J Cell Biol (1986) 1.41
The catabolism of L-arginine by Neurospora crassa. Biochim Biophys Acta (1967) 1.40
Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases. Eur J Biochem (1987) 1.40
Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci U S A (1992) 1.40
Frozen tissue sections as an experimental system to reveal specific binding sites for the regulatory subunit of type II cAMP-dependent protein kinase in neurons. Proc Natl Acad Sci U S A (1982) 1.40
Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity. EMBO J (2000) 1.40
Identification, characterization, and quantitative measurement of cyclic AMP receptor proteins in cytosol of various tissues using a photoaffinity ligand. J Biol Chem (1977) 1.40
Bio-availability of three formulations of glibenclamide. S Afr Med J (1989) 1.39
Von Willebrand disease caused by compound heterozygosity for p.r854q and p.r760c: diagnostic and therapeutic implications. Haemophilia (2010) 1.39
Molecular cloning and predicted full-length amino acid sequence of the type I beta isozyme of cGMP-dependent protein kinase from human placenta. Tissue distribution and developmental changes in rat. FEBS Lett (1989) 1.39
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Nitrogen regulation of arginase in Neurospora crassa. J Bacteriol (1977) 1.38
Regulation and function of glutamate synthase in Neurospora crassa. Biochem Biophys Res Commun (1980) 1.38
Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains. Mol Biol Cell (1998) 1.38
Genetics and physiology of Neurospora crassa glutamine auxotrophs. J Bacteriol (1978) 1.37
Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol (1989) 1.35
Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc Natl Acad Sci U S A (1981) 1.34
Taming platelets with cyclic nucleotides. Biochem Pharmacol (2001) 1.34
Characteristics of arginases from ureotelic and non-ureotelic animals. Biochem J (1965) 1.34
On the structure and function of different arginases. Biochim Biophys Acta (1966) 1.33
Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I. J Biol Chem (2000) 1.33
Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc Natl Acad Sci U S A (1994) 1.31
Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem (1986) 1.31
High-affinity binding of the regulatory subunit (RII) of cAMP-dependent protein kinase to microtubule-associated and other cellular proteins. Proc Natl Acad Sci U S A (1984) 1.30
NADH-dependent glutamate synthase and nitrogen metabolism in Neurospora crassa. Biochem Biophys Res Commun (1980) 1.29
Relation between structure and function of Neurospora crassa glutamine synthetase. Biochem Biophys Res Commun (1980) 1.27
Ammonium assimilation in Rhizobium phaseoli by the glutamine synthetase-glutamate synthase pathway. J Bacteriol (1988) 1.27
Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3',5'-monophosphorothioates. FEBS Lett (1990) 1.25
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation (2001) 1.24
Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol (1979) 1.24
A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry (2006) 1.24
The impact of maternal education on intrauterine growth: a comparison of former West and East Germany. Int J Epidemiol (2001) 1.22
Immunological distinction between guanosine 3':5'-monophosphate-dependent and adenosine 3':5'-monophosphate-dependent protein kinases. J Biol Chem (1980) 1.22
Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn Schmiedebergs Arch Pharmacol (1998) 1.22
Physiology of ammonium assimilation in Neurospora crassa. J Bacteriol (1982) 1.21
Nitrogen regulation of glutamine synthetase in Neurospora crassa. J Gen Microbiol (1978) 1.18
Pyruvate carboxylase from Rhizobium etli: mutant characterization, nucleotide sequence, and physiological role. J Bacteriol (1996) 1.17
Molecular cloning, cDNA structure, and regulation of the regulatory subunit of type II cAMP-dependent protein kinase from rat ovarian granulosa cells. J Biol Chem (1986) 1.17
Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator. J Clin Invest (1995) 1.17
Regulation of arginase activity by intermediates of the arginine biosynthetic pathway in Neurospora crassa. J Bacteriol (1972) 1.17
Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol (1992) 1.17
Expression of thiamin biosynthetic genes (thiCOGE) and production of symbiotic terminal oxidase cbb3 in Rhizobium etli. J Bacteriol (1997) 1.17
Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol (1999) 1.17
Neurospora crassa glutamine synthetase. Role of enzyme synthesis and degradation on the regulation of enzyme concentration during exponential growth. J Biol Chem (1977) 1.16
Nitrogen source regulates glutamine synthetase mRNA levels in Neurospora crassa. J Bacteriol (1978) 1.14
An alpha-actinin binding site of zyxin is essential for subcellular zyxin localization and alpha-actinin recruitment. J Biol Chem (1999) 1.11
Adenosine 3':5'-monophosphate receptor proteins in mammalian brain. J Biol Chem (1978) 1.11
Preliminary study of the inflammatory response to subcutaneous implantation of three root canal sealers. Int Endod J (2011) 1.11
The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization. Am J Physiol Cell Physiol (2007) 1.11
Identification of profilin and src homology 3 domains as binding partners for Drosophila enabled. Proc Natl Acad Sci U S A (1999) 1.11
Dibutyryl cAMP treatment of neuroblastoma-glioma hybrid cells results in selective increase in cAMP-receptor protein (R-I) as measured by monospecific antibodies. EMBO J (1983) 1.10
Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett (2004) 1.10
Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res (1995) 1.10
The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets. J Cardiovasc Pharmacol (2000) 1.10